Cargando…
Stromal control of oncogenic traits expressed in response to overexpression of GLI2, a pleiotropic oncogene
Hedgehog signaling is often activated in tumors, yet it remains unclear how GLI2, a transcription factor activated by this pathway, acts as an oncogene. We show that GLI2 is a pleiotropic oncogene. Overexpression induces genomic instability and blocks differentiation, likely mediated in part by enha...
Autores principales: | Snijders, Antoine M., Huey, Bing, Connelly, S. Thaddeus, Roy, Ritu, Jordan, Richard C. K., Schmidt, Brian L., Albertson, Donna G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643346/ https://www.ncbi.nlm.nih.gov/pubmed/19015636 http://dx.doi.org/10.1038/onc.2008.421 |
Ejemplares similares
-
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary
por: Kim, Sarah H., et al.
Publicado: (2020) -
Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021) -
Oncogenes overexpressed in metastatic oral cancers from patients with pain: potential pain mediators released in exosomes
por: Bhattacharya, Aditi, et al.
Publicado: (2020) -
MEDB-39. Oncogenic mechanisms underlying GLI2-amplified medulloblastoma
por: Murad, Najiba, et al.
Publicado: (2022) -
Genetic variations and alternative splicing: the Glioma associated oncogene 1, GLI1
por: Zaphiropoulos, Peter G.
Publicado: (2012)